Example: bankruptcy
ABPI CODE OF PRACTICE FOR THE PHARMACEUTICAL …
Clause 22 Non-Interventional Studies of Marketed Medicines 13.4 Yellow Section – Interactions with Health Professionals, Other Relevant Decision Makers, Healthcare Organisations, Patient Organisations and the Public, Including Patients and Journalists Clause 23 Donations and Grants MEGS in the form of Donations and Grants in 19.1, 19.2
Tags:
Information
Domain:
Source:
Link to this page:
Related documents
CLINICAL TRIALS REGULATION (EU) NO 536/2014
ec.europa.euinterpretation of Community law. This document aims at informing on the technical aspects of Commission Clinical Trials Regulation (EU) No 356/2014 with a view to facilitating its implementation. This documents sets out frequently-asked 'questions and answers' regarding the implementation of the rules on clinical trials.
Guideline on registry-based studies
www.ema.europa.euA registry-based study is either a clinical trial or a non-interventional study as defined in Article 2 of Regulation (EU) No 536/2014. The table in Annex I of the Questions & Answers Document - Regulation (EU) 536/2014 provides the difference between non-interventional studies and interventional trials.
Brief overview of biomarkers: value, limitations, and the ...
fnih.orgaddresses nuances of usage and interpretation among various stakeholders, including: ... Non-disease population Patients with disease Disease Subtype 1. Disease Subtype 2. Diagnostic ... – Interventional studies with “gold standard” endpoints compared to candidate – with
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euNon-interventional studies are defined by the methodological approach used and not by its scientific objectives. Non-interventional studies include database research or review of records where all the events of interest have already happened (this may include case- control, cross-sectional, cohort or